title: [Use of salbutamol in the treatment of severe hyperkalemia in hemodialysed patients].
abstract: The possibility of obtaining a rapid fall of kalaemia in patients with renal failure under haemodialysis by injecting salbutamol intravenously in doses of 0.5 mg over 15 minutes was tested in 11 subjects. Kalaemia fell by 1.08 +/- 0.30 mmol in 30 minutes, 75 per cent of the effect being obtained at the end of the infusion. Malaise with tachycardia was frequent but always transient. Thus, a rapid infusion of salbutamol seems to be well tolerated and effective against hyperkalaemia, provided two contra-indications are observed: coronary disease and treatment with beta-blockers.
authors.affiliation: Service de Néphrologie-Hémodialyse, Centre hospitalier, Carcassonne.
authors.forename: F
authors.initials: F
authors.lastname: de Cornelissen
authors.forename: H
authors.initials: H
authors.lastname: Bermudes
authors.forename: M
authors.initials: M
authors.lastname: Saint-Loubert
authors.forename: L
authors.initials: L
authors.lastname: Marty
authors.forename: C
authors.initials: C
authors.lastname: Emond
authors.forename: P
authors.initials: P
authors.lastname: Fontanier
mesh_terms: D000420:Albuterol / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006947:Hyperkalemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D007262:Infusions, Intravenous; D007676:Kidney Failure, Chronic; D006435:Renal Dialysis
chemical_list: D000420:Albuterol
vernacular_title: Utilisation du salbutamol dans le traitement de l'hyperkaliémie grave chez l'hémodialysé.